Investigating the Role of Insurance in Managing the Risks of Gene Editing Technologies

• <p> </p><div>

Chapter ONE

INTRODUCTION

• </div><ul><li>Background and significance of the study</li><li>Research objectives and questions</li><li>Scope and limitations of the research</li><li>Overview of the thesis structure</li></ul><div>

Chapter TWO

LITERATURE REVIEW

• Risks and Liabilities of Gene Editing Technologies</div><ul><li>Analysis of potential risks and unintended consequences of gene editing</li><li>Examination of liability issues and ethical considerations in gene editing applications</li><li>Case studies of gene editing-related incidents and their insurance implications</li></ul><div>

Chapter THREE

RESEARCH METHODOLOGY

• Current Insurance Landscape for Gene Editing Risks</div><ul><li>Assessment of existing insurance products and policies addressing gene editing risks</li><li>Analysis of the adequacy and gaps in insurance coverage for gene editing liabilities</li><li>Comparative study of insurance frameworks in different gene editing application domains</li></ul><div>

Chapter FOUR

DATA PRESENTATION AND ANALYSIS

• Leveraging Insurance to Manage Gene Editing Risks</div><ul><li>Recommendations for integrating gene editing risk assessment into insurance underwriting</li><li>Proposals for innovative insurance products tailored for gene editing applications</li><li>Ethical considerations and social implications of insuring gene editing technologies</li></ul><div>

Chapter FIVE

SUMMARY, CONCLUSION AND RECOMMENDATIONS

• Future Outlook for the Role of Insurance in Managing Gene Editing Risks</div><ul><li>Policy recommendations for regulatory frameworks supporting responsible gene editing insurance</li><li>Potential collaborations between insurers, researchers, and regulatory authorities</li><li>Opportunities for leveraging insurance to address emerging gene editing risks and liabilities</li></ul> <br><p></p>